Načítá se...
Intranasal oxytocin for autism spectrum disorders (ASD)
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy of intranasal oxytocin in improving social interaction and communication deficit, and other clinical outcomes in autism spectrum disorders (ASD), and to examine its safety.
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6465037/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010928.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|